When associated with the Nogo receptor (NgR), the transmembrane receptor p75 NTR signals growth cone collapse. Arrest of CNS axon growth in vivo is mediated by CNS myelin-derived inhibitory ligands through either an unknown pathway after NgR-and Ca
Introduction
One reason why transected central nervous system (CNS) axons fail to regenerate is probably because and either the pan neurotrophin receptor p75 NTR (Wang et al., 2002; Wong et al., 2002; Mi et al., 2004) or other signalling co-receptors, like TROY Shao et al., 2005 ) located on axon growth cones. Receptor binding induces Rho-A signalling of growth cone collapse (Barde, 1989; Barrett et al., 1998; Mukai et al., 2000) and an NgRand Ca
2+
-dependent mechanism that activates epidermal growth factor receptor (EGFR) mediated axon growth inhibition through an unknown pathway (Koprivica et al., 2005) . Since NgR binds a plethora of inhibitory ligands, single ligand knockout of, for example, Nogo-A fails to enhance robust CNS axon regeneration (Simonen et al., 2003; Zheng et al., 2003) . On the other hand, manipulation of Rho-A with C3 transferase and Rho kinase inhibitors blocks downstream inhibitory pathway activation, stimulates actin polymerization and allows growth cones to advance unimpeded (Dergham et al., 2002; Winton et al., 2002; Borisoff et al., 2003; Fournier et al., 2003; Ramer et al., 2004) .
Retinal ganglion cells (RGC) constitutively express NgR and/or p75 NTR and/or TROY, and the distal stump and scar of the transected optic nerve contains a full compliment of all known inhibitory ligands (Chierzi and Fawcett, 2001) . Paradoxically, however, after intravitreal sciatic nerve grafting (Berry et al., 1996 (Berry et al., , 1999 and lens injury (Leon et al., 2000; Fischer et al., 2001; Lorber et al., 2002; Yin et al., 2003) , transected RGC axons in the rat and mouse do regenerate through the inhibitory ligand-rich environments of both the incipient scar and distal myelinated optic nerve and chiasm. In the former model, we have shown that regenerating RGC axons secrete matrix metalloproteinases (MMP) and downregulate the expression of tissue inhibitors of MMP (TIMP) in optic nerve glia, which probably attenuates scarring in the lesion (Ahmed et al., 2005a) .
As CNS axons are generally incapable of regeneration, we investigated why intravitreal peripheral nerve (PN) implants in adult rats stimulated the regeneration of severed RGC axons though the inhibitory ligand-rich distal optic nerve (Berry et al., 1996 (Berry et al., , 1999 . We hypothesized that Schwann cell-derived factors, supplied through an intravitreal PN implant (Berry et al., 1996 (Berry et al., , 1999 , modulate NgR, p75 NTR and TROY on RGC axon growth cones, thereby abrogating inhibitory ligand binding and signalling. In this study, we compared the integrity of Nogo-A, NgR, p75 NTR and TROY in retina and optic nerve in our regenerating (RM) and non-regenerating (NRM) in vivo rat optic nerve crush models. In the RM, whilst there was elevated expression of all three receptors post-injury, they were also cleaved with associated attenuation of Rho-A signalling, and, additionally, Nogo-A was fragmented, possibly explaining why axons regenerate in the transected optic nerve after intravitreal PN grafting. After Schwann cell-derived factor/neurotrophic factor (NTF) stimulation in vivo and in vitro, respectively, levels of active tumour necrosis factor-a converting enzyme (TACE, which has a-secretase activity) were elevated in RGC regenerating their axons. TACE initiates regulated intramembranous proteolysis (RIP) of p75 NTR , a process in which the 55 kDa extracellular domain (p75 ECD ) is first cleaved from p75 NTR by a-secretase, leaving a 32 kDa cytoplasmic transitional product p75 CTF from which the 25 kDa intracellular domain (p75 ICD ) is secondarily cleaved by a gsecretase (Logan et al., 2006) . Complete removal of p75 NTR , by siRNA-mediated mRNA knockdown in vitro (Ahmed et al., 2005b) , significantly enhances disinhibition of neurite outgrowth of ciliary neurotrophic factor (CNTF) stimulated RGC in the presence of inhibitory CNS myelin extracts. Paralysis of p75 NTR signalling by siRNA suppresses Rho-A activation, favouring actin polymerization in growth cones, thereby promoting CNTF-stimulated neurite growth in the presence of CNS myelin. We also show that EGFR-mediated axon growth inhibition (Koprivica et al., 2005) is reduced in RM retinae and optic nerves by reduced phosphorylation of EGFR, probably resulting from suppressed NgR-mediated Ca 2+ signalling.
Methods

Animals and treatment groups
All animal procedures were licensed by the UK Home Office. Adult, female 200-250 g Fischer rats were anaesthetized with Hypnorm/Hypnovel anaesthesia (Janssen Pharmaceuticals, Oxford, UK). The experimental groups comprised RM in which the optic nerve was crushed (ONC) intraorbitally and a freshly teased segment of the sciatic nerve immediately transplanted intravitreally (intravitreal PN graft) and held in place with Sterispon gelatine sponge (Johnson and Johnson, UK), and NRM in which the optic nerve was crushed (ONC) without intravitreal sciatic nerve implantation. Five additional groups separately controlled for (i) baseline parameters, using untreated intact rats, that is, 0 day controls; (ii) effects of an intravitreal sciatic nerve implantation without ONC, that is, PN no ONC; (iii) intravitreal inflammation and effects of scleral/vitreal injury without ONC, by intravitreal Sterispon implantation alone; (iv) intravitreal inflammation and effects of scleral/vitreal injury with ONC, by intravitreal Sterispon implantation and ONC; and (v) presence of non-proteinaceous sciatic nerve-derived growth factors, by intravitreal implantation of freeze/thawed sciatic nerve to denature all proteins and kill all Schwann and other sciatic nerve cells. None of the animals developed cataracts, confirming that the lens had not been injured during surgery. The optic nerve was exposed through a supraorbital approach and crushed using forceps as described previously (Berry et al., 1996 (Berry et al., , 1999 . Optic nerves and retinae were processed for RNAse protection assay, western blotting and immunohistochemistry at 6, 8 and 20 days post-injury (dpi), as described below.
Preparation of CNS myelin extract
A CNS myelin extract was prepared as described by us elsewhere. The extract has been shown to contain Nogo-A, oligodendrocyte myelin glycoprotein (OMgp), myelin-associated glycoprotein (MAG) and chondroitin sulphate proteoglycans (CSPG) (Ahmed et al., 2005b) .
Germany) cloned into the Pst I/Sac II site of pBluescript KS + was used to detect p75 NTR mRNA. Cyclophilin (peptidyl-propyl cis-transisomerase) cDNA, a housekeeping gene, was used as a reference DNA (from Dr J. Douglass, Oregon Health Sciences University, Portland, Oregon, USA), utilizing a 295-bp fragment (coding region) of the rat cyclophilin cDNA cloned into the Pst I/BamH I sites of pSP65.
Total RNA was prepared from the retinae of groups of three animals per time-point using RNA-B (Biogenesis, Southampton, UK) and RNAse protection assay was performed according to the method described elsewhere (Smith et al., 2001) . Autoradiographs were digitally scanned and intensities of bands corresponding to p75 NTR and its cleaved fragments were quantified using NIH Image software (NIH, USA). For control animals, the mean intensity was given a value of 1.0 and the relative fold-change in lesioned animals was calculated. mRNA levels were internally standardized by quantifying cyclophilin mRNA levels. Data were examined statistically by one-way analysis of variance (ANOVA) with results judged as significant at P < 0.05.
Tissue preparation and immunohistochemistry
Groups of at least three rats were killed by anaesthetic overdose and perfusion fixed with 4% paraformaldehyde, and their retinae and optic nerves were excised, cryoprotected, immersed in OCT (Miles Inc., CA, USA) and frozen in liquid nitrogen. Longitudinal cryostat sections, 10 mm thick, were cut (Bright Instrument Co. Ltd., Cambridgeshire, UK) at 4 C, collected onto Vectabond coated slides (Vector Laboratories, Cambridgeshire, UK), air dried and processed for immunohistochemistry as described previously (Lorber et al., 2002) . Cultured retinal cells on glass coverslips were fixed in 4% paraformaldehyde and also processed as described previously (Lorber et al., 2002) .
In situ hybridization
Longitudinal cryostat retinal sections, 10 mm thick, were collected onto charged slides (Vector Laboratories), air dried and processed for in situ hybridization using a TSA Biotin System (NEN Life Sciences Inc., Boston, MA) as described previously (Lagord et al., 2002) . Oligonucleotide probes used for p75 NTR (Radeke et al., 1987; Suzuki et al., 1998) and TACE (Black et al., 1997) were designed from published sequences.
Protein extraction and western blotting
At 0, 6, 8 and 20 dpi, three rats in each treatment group were killed, both retinae and optic nerves were dissected, and proteins were extracted and processed for western blotting as described previously (Winton et al., 2002) . The experiment was repeated three times. To determine levels of p75 NTR in siRNA-treated RGC cultures by western blotting, 375 · 10 3 cells/siRNA treatment (n = 6) were lysed and blotted as described previously (Ahmed et al., 2005b) .
Affinity precipitation of Rho-GTP GTP-bound Rho was assayed from tissues and cell lysates using a Rho activation assay kit (Upstate Biotechnology, Milton Keynes, UK) following the manufacturer's instructions as described elsewhere (Dubreuil et al., 2003) .
In situ Rho-GTP pull-down assay
In situ localization of Rho-GTP was performed according to a modified earlier published method (Dubreuil et al., 2003) . Briefly, 10 mm thick frozen sections of retinae were post-fixed in 4% paraformaldehyde and incubated with either glutathione-S-transferase (GST)-RBD or GST alone (both from Upstate Biotechnology) overnight at 4 o C. Sections were then washed 3· in phosphate-buffered saline (PBS), blocked in 3% bovine serum albumin for 1 h at room temperature and incubated with an anti-GST antibody (New England Biolabs, Hertfordshire, UK) and bIII-tubulin antibody (Sigma) overnight at 4 C. Sections were then washed in PBS, incubated with either FITC or Texas red secondary antibodies (Molecular Probes), mounted in Fluorsave (Calbiochem) and viewed under an epi-fluorescent microscope (Zeiss, Hertfordshire, UK).
Adult retinal cultures
Adult rats (6-8-weeks old) were killed by cervical dislocation, and the retinae were removed by dissection and dissociated using a papain system according to the manufacturer's protocol (Worthington Biochem, New Jersey, USA). Cultures of 125 · 10 3 dissociated retinal cells, containing RGC, were grown on glass coverslips pre-coated with 100 mg/ml poly-D-lysine (Sigma, Dorset, UK) and 20 mg/ml merosin (Chemicon, Harrow, UK) in 4-well tissue culture plates (Nunc, UK) in supplemented Neurobasal-A (Invitrogen) medium for 4 days at 37 C in a humidified 5% CO 2 atmosphere.
Treatment of retinal cultures with NTF, TACE and modulators of enzyme activity
Experimental adult retinal cultures were grown on glass coverslips in triplicate as described above and subjected to treatment with either 25 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma) to stimulate TACE production (Kanning et al., 2003; Weskamp et al., 2004) , or a combined cocktail of recognized Schwann cell-derived NTF, consisting of CNTF (10 ng/ml), neurotrophin-3 (NT-3) (50 ng/ml), fibroblast growth factor 2 (FGF-2) (10 ng/ml) and brain-derived neurotrophic factor (BDNF) (50 ng/ml) (all from Peprotech, London, UK), to stimulate TACE production. Retinal cultures were also treated with either recombinant TACE enzyme (10 ng/ml) (R & D Systems, UK) to cleave p75 ECD , active human TIMP3 enzyme (5 mg/ml, Chemicon) to inhibit TACE activity (Karan et al., 2003; Black et al., 2004) , or g-secretase inhibitor (30 mM) (S2188, Sigma) to block p75 ICD cleavage. Cells were treated for 48 h before harvesting for western blotting and subsequent quantitative assessment of proteins by densitometry as described below. Retinal cultures in the presence or absence of myelin were either (i) untreated; or (ii) treated with (a) combined NTF; (b) combined NTF with a TACE inhibitor, TIMP3; (c) TACE; (d) combined NTF and TACE; (e) combined NTF with a TACE activator, PMA; (f) combined NTF with a g-secretase inhibitor (S2188); or (g) combined NTF with TACE and a g-secretase inhibitor (S2188).
siRNA preparation and transfection
To design target-specific siRNA duplexes, five siRNA sequences directed against the open reading frame of rat p75 NTR mRNA, NCBI accession number NM012610 (Ahmed et al., 2005b) , were selected using criteria set out elsewhere (Elbashir et al., 2001 ).
Oligonucleotide templates and control scrambled sequences were chemically synthesized (Alta Biosciences, University of Birmingham, UK) and siRNA sequences were constructed using the Silencer siRNA Construction kit (Ambion, Texas, USA).
RGC were transfected with siRNA using Oligofectamine reagent (Invitrogen) in 4-well tissue culture plates (Nunc) according to the manufacturer's instructions (Invitrogen). After 5 h of transfection, supplemented Neurobasal-A medium was added and incubated for a further 72 h in the presence/absence of CNS myelin and CNTF before either cell lysis or immunocytochemistry as described above.
Antibodies
RGC and their neurites/axons were recognized using monoclonal bIII-tubulin antibody at 1 : 100 (Sigma, Poole, UK). Polyclonal growth-associated protein 43 (GAP-43) antibody was used at 1 : 400 for both western blots and immunohistochemistry to detect regenerating axons. Polyclonal anti-p75 NTR (Promega, Southampton, UK), was used at 1 : 500 for western blots and immunohistochemistry/cytochemistry, which recognizes intact p75 NTR , p75 ECD , p75 CTF and p25 ICD . Goat anti-human NgR (1 : 100), TROY (1 : 500) and phosphorylated EGFR (all from Santa Cruz, CA, USA) were used in western blots at 1 : 400. Monoclonal anti-EGFR antibody (Novocastra, Newcastle upon Tyne, UK) was used to detect total EGFR in western blots at 1 : 400. Rabbit polyclonal TACE (Neomarkers, CA, USA) was used at 1 : 500 dilution for both western blotting and immunohistochemistry. Chicken anti-presenilin-1 (PS1, Cambridge Bioscience, Cambridge, MA, USA) was used at 1 : 200 in western blots.
Densitometry
Western blots were scanned digitally in Adobe Photoshop keeping scanning parameters the same for all blots to provide a densitometric value for bands of interest. TIFF files were then analysed in ScionImage (version 4.0.2, Scion Corp, Maryland, CA, USA) using the built-in gel-plotting macros. The integrated density of each band in each lane was calculated for three separate blots from three independent experiments.
Quantification of neurite outgrowth and RGC survival
The mean number of RGC with neurites and mean neurite length were quantified by splitting each coverslip into nine quadrants and randomly capturing images of bIII-tubulin immunostained RGC from each quadrant using a Zeiss Axioplan epi-fluorescent microscope. Axiovision image analysis software (Zeiss, Hertfordshire, UK) was then used to measure neurite length and count the number of RGC in each coverslip as described previously (Lorber et al., 2002) using the built-in macros (n = 9 coverslips/condition).
Statistical analysis
The significance of differences between sample means were calculated using GraphPad Prism (GraphPad Software Inc., Version 4.0, CA, San Diego, USA) by one-way ANOVA followed by post hoc testing with Dunnett's method.
Results
In vivo optic nerve regeneration Upregulation of GAP-43 correlates with RGC axon regeneration
We have confirmed the original observation of Berry et al. (1996 Berry et al. ( , 1999 ) that up to 10% of RGC axons regenerate in the transected optic nerve 20 days after intravitreal sciatic nerve (PN) implantation (Fig. 1A) . PN-induced axon regeneration was correlated with increased GAP-43 titres in the optic nerve ( Fig. 1B and C) . Although there was little or no GAP-43 in 0 day intact control RGC axons, after intravitreal PN implantation without optic nerve crush (PN no ONC), optic nerve GAP-43 levels rose slightly over time, but expression was less than that seen after ONC either without (NRM) or with (RM) intravitreal PN implantation ( Fig. 1B and C) . Compared with GAP-43 levels seen in the optic nerve from both 0 day intact and PN no ONC controls, GAP-43 levels were increased by 6 dpi in NRM and RM optic nerves (RM > NRM, P < 0.0001). Thereafter, GAP-43 levels fell rapidly in the optic nerves from the NRM, whereas, in the RM, they increased further at 8 dpi, and these raised levels were maintained up to 20 dpi.
Retinal p75 NTR expression
The cellular localization of p75 NTR in the adult rat retina is controversial. For example, in adult rats, p75 NTR protein is found in Müller cell processes (Hu et al., 1998 (Hu et al., , 1999 , while mRNA is expressed in RGC (Carmignoto et al., 1991) . However, we observed expression of p75 NTR protein ( Fig. 2A ) and mRNA ( Fig. 2B and C) in a sub-population of 30% of normal and axon transected adult rat RGC. Lower levels of p75 NTR protein were also observed in the inner plexiform layer, probably associated with RGC dendritic fields, and occasional cells in the inner nuclear layer (INL) containing horizontal, amacrine and bipolar neurons ( Fig. 2A) . The levels of p75 NTR mRNA rose 2-fold in the first 8 dpi in extracts of whole RM and NRM retinae and a further 2-fold in extracts of whole RM retinae by 20 dpi, compared with intact 0 day controls ( Fig. 2D and E) .
Modulation of inhibitory receptors in RM retina
In RM and NRM retinae, NgR and TROY levels rose postinjury (Fig. 3A) . There was an incrementing appearance of cleaved TROY fragments in RM compared with NRM retinae (Fig. 3A) . Titres of full-length p75 NTR and p75 ECD increased in extracts of NRM retinae by 6 dpi compared with 0 day controls, and remained elevated until 20 dpi ( Fig. 3A and B) , an observation that correlated with the enhanced levels of retinal p75 NTR mRNA ( Fig. 2D and E) . By contrast, despite rising levels of p75 NTR mRNA, full-length p75 NTR disappeared in RM retinae as titres of p75 ECD , p75 CTF and p75 ICD increased proportionally ( Fig. 3A and B) , suggesting that p75 ECD and p75 ICD were generated by post-translational cleavage of p75 NTR and p75 CTF , respectively. Post-injury fragmentation of RM p75 NTR was also correlated with a failure of Rho-GDP to convert to Rho-GTP, although total Rho-A levels remained constant. At 8 dpi, for example, Rho-GTP was greatly reduced at 8 and 20 dpi in RM compared with NRM retinae and RGC, respectively ( Fig. 3A and C-E) . Limited proteolytic fragmentation of p75 NTR occurred by 6 days in intact controls that received an intravitreal PN implant (PN no ONC 5% > 0 day control, not shown). The disappearance of full-length p75 NTR was correlated with reduced phosphorylation of EGFR at 8 and 20 dpi, without changes in total EGFR (Fig. 3A) .
Modulation of inhibitory receptors in the RM optic nerve p75 NTR mRNA was neither expressed in RM nor NRM optic nerves (Fig. 4A ), although at all dpi there were high titres of total p75
NTR protein compared with intact 0 day controls. Increasing levels of p75 ECD and p75 ICD were detected over time in both RM and NRM optic nerves, with higher titres in the RM (Fig. 4B ), which correlated with local cleavage after synthesis of p75 NTR in RGC somata and anterograde axonal transport into the optic nerve. Rapid cleavage of p75 CTF may account for the presence of p75 ICD and absence of p75 CTF in the optic nerve post-injury. There was also some postinjury proteolysis of TROY, with the appearance of higher levels of a 42-kDa cleaved fragment at 8 and 20 dpi in RM than in NRM optic nerves (Fig. 4B) . As in the RM retinae, disappearance of full-length p75 NTR was correlated with reduced phosphorylation of EGFR at 8 and 20 dpi, without changes in total EGFR (Fig. 4B ).
Fragmentation of Nogo-A in RM retina and optic nerve
There was limited cleavage of Nogo-A in RM retinae (data not shown) but, in the optic nerves, full-length Nogo-A disappeared by 8 dpi, coincident with the appearance of multiple cleaved Nogo-A fragments (Fig. 4B) . Elsewhere we have shown that MMP (distinct from TACE) secreted by RGC growth cones/optic nerve glia probably degrade ON Nogo-A (Ahmed et al., 2005a) (see Fig. 2C ).
Fig. 1 GAP-43
+ axons (A) in the optic nerve of the (i) NRM and (ii) RM at 20 dpi. GAP-43 + axons regenerate through the lesion and distal optic nerve segment in the RM, but not NRM (asterisks indicate lesion site, scale bar = 200 mm). Representative western blot (B) and (C) densitometric data of GAP-43 from pooled optic nerve protein in intact 0 day controls, intravitreal PN implant alone (PN no ONC) controls, and from RM and NRM, at 6, 8 and 20 dpi (n = 6/experiment, three independent experiments).
TACE activity in vivo and in vitro TACE induces RIP of p75 NTF in vivo At all dpi, there was an upregulation and activation of both pro-and active-TACE, and higher levels of presenilin-1 (PS1), a component of g-secretase, in RM but not NRM retinae ( Fig. 5A and C) . At 20 dpi, there were higher levels of TACE immunoreactivity in RM compared with NRM RGC (Fig. 5B ) and occasional GAP-43+ axons in the optic nerve (not shown). Levels of pro-and active-TACE rose post-injury in both RM and NRM lesioned optic nerves with the active form predominating in the former (Fig 5C) . There was a small increase in TACE and GAP-43 in RGC of PN no ONC control, with a modest proportional enhancement of p75 NTR fragmentation, but there was no change in levels of downstream Rho-GTP (not shown). All other controls detailed in the Methods section showed no modulation of these proteins, confirming that inflammatory/macrophage cell-derived factors did not contribute to receptor shedding in RM optic nerves and retinae (not shown).
TACE-mediated disinhibition of RGC neurite outgrowth in vitro
After addition of a combination of pre-optimized concentrations of known Schwann cell-secreted neurotrophic factors, CNTF, BDNF, NT-3 and FGF-2, to adult rat retinal cultures, levels of both active (*) and pro forms (arrow) of TACE were significantly increased; the former enhanced by 43% over that seen after TACE activator (PMA) treatment (P < 0.0001) (Fig. 6A) . Addition of the TACE inhibitor TIMP3 (Karan et al., 2003; Black, 2004) abolished active-TACE production in retinal cultures.
We then tested whether the addition of exogenous TACE to adult rat retinal cultures disinhibited RGC neurite outgrowth in the presence of a pre-determined inhibitory concentration of CNS myelin extract by initiating RIP of p75 NTR , TROY ECD /NgR ECD shedding and decrementing both phosphorylation of EGFR and Rho activation. Treatment with exogenous TACE alone, or with the NTF combination, completely cleaved p75 NTR into p75 ECD , p75 CTF and NTR and activation of Rho-A and EGFR in the RM versus NRM retinae. (A) Representative western blots and immunoprecipitation (n = 3/experiment, three independent experiments) to show levels of NgR, TROY, p75 NTR , p55 ECD , p75 CTF , p25 ICD , Rho-GTP, total Rho, phosphorylated and total EGFR, and b-actin within samples of pooled retinal protein from 0 day intact controls, and RM and NRM at 6, 8, and 20 dpi. Densitometry of western blots (B) to show relative levels of p75 NTR , p75 ECD and p75 ICD levels (n = 3, three independent experiments; **P < 0.001; ***P < 0.0001). (C) Mean changes in Rho-GTP compared with total Rho in intact 0 day controls, and in RM and NRM at 6, 8 and 20 dpi (n = 3/experiment, three independent experiments; **P < 0.001; ***P < 0.0001). (D) Representative double immunohistochemistry of p75 NTR (green) and bIII-tubulin (red) in retinae from intact 0 day controls, and from RM and NRM retinae at 20 dpi. (E) Representative in situ Rho-GTP (green) and bIII-tubulin (red) in intact 0 day controls, and RM and NRM retinae at 20 dpi. (For D and E, scale bar = 10 mm; GCL = ganglion cell layer, IPL = inner plexiform layer).
p75 ICD , blocked Rho activation, reduced phosphorylation of EGFR ( Fig. 6B and C) and enhanced NTF-stimulated RGC neurite outgrowth in the presence of CNS myelin extract (Fig. 7A-D) . The numbers of RGC with neurites ( Fig. 7B ) and mean neurite lengths (Fig. 7C) were increased, although RGC survival was not affected (Fig. 6D) . After the addition of the TACE activator, PMA, NTF-stimulated RIP of p75 NTR in retinal cultures was further potentiated (Fig. 6B and C) , and this correlated with the suppression of Rho activation and reduced EGFR phosphorylation. The TACE inhibitor, TIMP3, blocked NTF-induced RIP of p75 NTR and NgR fragmentation, but did not affect EGFR phosphorylation (Fig. 6B  and C) . Levels of Rho-GTP and NgR were restored to normal ( Fig. 6B and C) , and RGC neurite outgrowth was inhibited in the presence of CNS myelin extracts (Fig. 7A-D) . The treatment of cultures with NTF and a g-secretase inhibitor (S2188) elicited p75 ECD shedding but neither proteolysis of p75 CTF nor reduced phosphorylation of EGFR and Rho-A activation occurred allowing CNS myelin to inhibit RGC neurite outgrowth ( Fig. 6B and C; Fig. 7B and C) . Addition of TACE to the NTF/S2188 treatment promoted p75 NTR fragmentation and p75 ECD shedding into the medium without generating p75 ICD , and reduced both phosphorylation of EGFR and Rho activation, leading to RGC neurite outgrowth equivalent to that seen in the absence of CNS myelin (Figs 6B and C, and 7A and C). Whenever p75 NTR was cleaved, most p75 ECD was shed into the medium, although some was retained in the cell fraction probably bound to as-yet-unspecified sites in the plasmalemma.
Nogo-A fragmentation in vitro
TACE did not cleave Nogo-A (Fig. 6B, lane 4) but, when NTF were added to the medium, fragmentation of Nogo-A occurred that was not blocked by the TACE inhibitor TIMP3, indicating that proteolysis was mediated by MMP other than TACE (Fig. 6B, lane 3) .
siRNA knockdown of p75 NTR disinhibits CNTF-stimulated RGC neurite outgrowth
In retinal cultures, 100 ng/ml of non-Trk-dependent CNTF, a potent RGC neurotrophic factor known to be expressed by Schwann cells (Stockli et al., 1989; Meyer et al., 1992; Watabe et al., 1995) , promoted optimal RGC neurite outgrowth. Inhibition of CNTF-mediated neurite outgrowth was optimal in 10 mg/ml of rat CNS myelin extract that contained significant amounts of Nogo-A, OMgp, MAG and CSPG (Ahmed et al., 2005b) . In all control retinal cultures, full-length NTR , p75 ECD , p75 CTF , p75 ICD , phosphorylated and total EGFR, and b-actin taken from optic nerves of intact 0 day controls, and from RM and NRM at 6, 8 and 20 dpi.
p75
NTR and Rho-GTP were detected (Fig. 8A) . After delivery of sequences 1-5 of p75 NTR siRNA, sequence 2 caused 100% knockdown of p75 NTR , whilst sequences 1 and 3 induced 70-80% knockdown of p75 NTR (Fig. 8A) , as assessed by densitometry and when compared with p75 NTR levels in untransfected cells in the presence of CNS myelin. Rho-GTP, but not total Rho, was absent after treatment with sequences 1, 2 and 3 ( Fig. 8A and B) . Scrambled control sequence 2 modulated neither p75 NTR nor Rho-GTP (Fig. 8B ). p75 NTR knockdown and associated suppression of Rho-A activation with sequence 2 were both correlated with a 5-fold increase in the mean number of RGC with neurites [ Fig. 8C(i) ] and the mean neurite length [ Fig. 8C(ii) ] in the presence of CNS myelin extract and CNTF, compared with that seen with CNTF alone. Moreover, both downregulation of p75 NTR and the subsequent failure in Rho-A activation were correlated with a significant increase in RGC survival after 4 days in culture [ Fig. 8C(iii) ]. Sequence 2 enhanced RGC neurite outgrowth 2-fold above that observed in CNTF-stimulated RGC cultured without inhibitory CNS myelin ligands. There was no p75 NTR immunostaining of RGC somata and neurites transfected with sequence 2, whilst control untransfected RGC and RGC transfected with the corresponding scrambled sequence were p75 NTR immunostained (Fig. 8D ).
Discussion Neurotrophic activity of intravitreal peripheral nerve implants
Sciatic nerve grafts, containing Schwann cells, implanted either intravitreally or onto the cut end of the optic nerve, support robust RGC axon regeneration (Berry et al., 1996 (Berry et al., , 1998 (Berry et al., , 1999 . Moreover, after killing all Schwann cells in the sciatic nerve implants using a freeze-thawing cycle, the number of regenerating RGC axons is greatly reduced, confirming that Schwann cells secrete axogenic molecules. Identified Schwann cell-derived NTF include nerve growth factor (NGF) (Assouline et al., 1987; Bandtlow et al., 1987; Matsuoka et al., 1991; Weidner et al., 1999) , BDNF (Acheson et al., 1991; Meyer et al., 1992; Funakoshi et al., 1993) , NT-3 (Funakoshi et al., 1993; Cai et al., 1998; Meier et al., 1999) , neurotrophin-4/5 (NT-4/5; NT-4) (Ming et al., 1999) , FGF-2 (Grothe et al., 2001) and CNTF (Stockli et al., 1989; Meyer et al., 1992; Watabe et al., 1995) . Logan et al. (2006) show that at least three of these NTF in combination (BDNF, FGF-2 and NT-3) synergistically promote RGC axon growth in the severed optic nerve after intravitreal delivery. Since Schwann cells remain viable in intravitreal grafts (Berry et al., 1996) , their potential to secrete NTF is conserved for the duration of our in vivo experiments. We also have evidence that treatment of cultured RGC with PNconditioned medium significantly enhances RGC neurite outgrowth and that mAb228 (a blocker of gp130, a component of CNTF and LIF receptors), reverses this neuritogenic effect, demonstrating that a diffusible factor is released from Schwann cells that promotes RGC neurite outgrowth (observations by Lorber et al. in our laboratory). The NTF used for our in vitro studies were chosen as known components of the Schwann cell NTF repertoire. 
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The axiogenic efficacy of intravitreal PN grafting is confirmed in this series of experiments, with enhanced numbers of GAP-43+ RGC axons visible in optic nerve sections and increased levels of GAP-43 protein measured in optic nerve extracts after ONC in the RM. Like Fischer et al. (2001) and Leon et al. (2002) (who used the same injury model, but promoted regeneration via macrophage/lens-derived factors), we also observe GAP-43 expression in control animals without optic nerve transection but with intravitreal PN implants (PN no ONC controls). These observations suggest that Schwann cell-derived factors from the PN implant promote a state of growth readiness in RGC.
Paradoxical regeneration of RGC axons in the inhibitory environment of the optic nerve
In this study, we investigate the paradox that Schwann cellderived factors stimulate RGC axons to regenerate through the inhibitory myelin-rich distal segment of the transected and (D) mean number of surviving RGC after treatment with NTF with no added CNS myelin extract, NTF plus CNS myelin extract, TACE with no CNS myelin extract, TACE plus CNS myelin extract, NTF plus TACE plus CNS myelin extract, NTF plus TACE plus TIMP3 plus CNS myelin extract (***P < 0.0001; scale bar = 50 mm). NTF = CNTF/BDNF/NT-3/FGF-2. Note: in this experiment myelin was added at titres that completely suppress NTF-stimulated neurite outgrowth (arrow). NTR , p75 ECD , p75 ICD , Rho-GTP, total Rho and b-actin after siRNA-mediated silencing of p75 NTR from control retinal cultures without CNS myelin extract, and cultures grown in the presence of CNTF without CNS myelin, and CNTF plus sequences 1-5 of p75 NTR siRNA separately in the presence of CNS myelin extract. (B) Western blot/immunoprecipitation (n = 3) of p75 NTR , p75 ECD , p75 ICD , Rho-GTP, total Rho and b-actin after siRNA-mediated silencing of p75 NTR from control cultures without CNS myelin extract; grown in the presence of CNTF alone; CNTF plus either scrambled sequence 2, or sequence 2 of p75 NTR siRNA without CNS myelin extract; and either scrambled sequence 2 or sequence 2 of p75 NTR siRNA with CNS myelin extract. (C) Quantification of (i) mean number of RGC with neurites, (ii) mean RGC neurite length, and (iii) mean number of RGC in control retinal cultures, and in retinal cultures treated with and without CNTF with no added CNS myelin, and CNTF with sequence 2, and scrambled sequence 2 of p75 NTR siRNA without myelin extract, and CNTF with sequences 1-5 of p75 NTR siRNA in the presence of CNS myelin extract (***P < 0.0001). (D) Double immunocytochemistry to show bIII-tubulin + RGC (red) co-stained with p75 NTR (green) in control retinal cultures (CNTF without CNS myelin extract), and retinal cultures treated with sequence 2, and scrambled sequence 2 of p75 NTR siRNA with CNS myelin extract (scale bars = 50 mm). NTR also occurs in vitro after the addition of exogenous TACE, which disinhibits NTF-stimulated RGC neurite outgrowth in the presence of inhibitory CNS myelin. Significant disinhibition of NTF-stimulated RGC neurite outgrowth in the presence of inhibitory CNS myelin is promoted by siRNA-mediated ablation of p75 NTR . The paradox may, therefore, be explained if Schwann cell-derived factors induce a-and g-secretase activity in RGC that cleave p75 NTR in RGC somata and growth cones, whilst additional MMP released from RGC axons and their surrounding glia in the optic nerve cleave Nogo-A (see also Ahmed et al., 2005a) , paralyzing inhibitory signalling through the p75 NTR /NgR/Lingo-1 complex. The suppression of EGFR activation is probably effected after RIP of p75 NTR and p75 NTR /TROY/NgR ECD shedding and consequent attenuation of Ca 2+ influx. Growth cone collapse is thus suppressed by inactivation of both EGFR and Rho-A signalling, and RGC axon regeneration is disinhibited through the optic nerve. Schwann cell-derived factors stimulate axon regeneration in RM optic nerves and induce fragmentation of Nogo-A (and possibly other myelin-derived inhibitors) through increased MMP and decreased TIMP activity in the optic nerve, which also accounts for the absence of scarring in these animals (Berry et al., 1996 (Berry et al., , 1999 Ahmed et al., 2005a; Logan et al., 2006) . Not all RGC express p75 NTR , although most express TROY, both in vivo and in vitro. The in vitro observation that 20% RGC grow neurites in the presence of the CNTF/BDNF/NT-3/FGF-2 combination suggests that p75 NTR and TROY are differentially active in RGC and that other factors determine RGC axon regenerative potential.
Schwann cell-derived factor-induced RIP of p75
NTR
In the optic nerve, significant amounts of p75 NTR protein are present, although p75 NTR mRNA is not detected, suggesting that the latter is manufactured in RGC somata and anterogradely transported in their axons along the optic nerve. In both RM retinae and optic nerves, the levels of p75 ECD , p75 CTF and p75 ICD are inversely proportional to those of full-length p75 NTR , supporting the conclusion that these fragments are products of p75 NTR RIP. p75 NTR cleavage correlates with enhanced production and activation of a-(TACE) and g-secretase (PS1), both of which are required for RIP of p75 NTR (Jung et al., 2003; Kanning et al., 2003) . In support of our in vivo observations of both ectodomain shedding and RIP of inhibitory receptors, RGC upregulated levels of pro-and active-TACE in vitro in response to combined CNTF/BDNF/NT-3/FGF-2 treatment. No p75 ECD shedding occurs in response to either single NGF and BDNF administration, or after pro-NTF binding (Jung et al., 2003; Kanning et al., 2003) but, in our hands, stimulation with combined CNTF/BDNF/NT-3/FGF-2 upregulated RGC TACE production in vitro, leading to RIP of p75 NTR . We have already reported that treatments with other combinations of NTF produce synergistic RGC survival and axonal growth together with RIP of p75 NTR (Logan et al., 2006) . Astrocytes and endothelial cells constitutively express TACE in the intact CNS (Goddard et al., 2001) , and our results localize pro-and active-TACE to RGC and optic nerve glia. Numerous integral membrane proteins (Peschon et al., 1998; Mullberg et al., 2000) are proteolytically cleaved near their membrane insertion to liberate soluble ECD into the pericellular space (Ehlers and Riordan, 1991; Hooper et al., 1997; Baumann and Frank, 2002) . The shed soluble p75 ECD may act as a p75 NTR signalling antagonist by competing with full-length p75 NTR and/or TROY for NgR/Lingo-1 binding, thereby potentiating the disinhibition of axon regeneration already promoted by RIP-mediated paralysis of p75 NTR inhibitory transduction. p75 ICD has several potential downstream targets, including NF-kB that mediates gene transcription (Kanning et al., 2003) regulated neuronal apoptosis (Barrett, 2000; Yamashita et al., 2002) . Many proteins with nuclear functions interact with the p75 ICD (Roux and Barker, 2002) , including the p75 NTR -associated cell death executor (NADE), which signals survival/apoptosis in the presence of NTF (Mukai et al., 2000) . The activation of apoptosis may account for the 80-90% RGC death observed after optic nerve transection, even after intravitreal PN implantation (Berry et al., 1996 (Berry et al., , 1999 . In developing neurons of p75 ICD over-expressing transgenic mice, p75 ICD induces extensive neuronal apoptosis (Majdan et al., 1997) , and pro-apoptotic signalling of p75 ICD is also observed in cultured cells (Coulson et al., 2000; Roux and Barker, 2002) . However, in the RM, PN-derived NTF do not enhance apoptosis, since significantly greater RGC survival is observed in RM compared with NRM (Berry et al., 1996 (Berry et al., , 1999 . In this study, the same protective effect of NTF on RGC survival was observed in vitro, even in the presence of TACE, suggesting that unidentified NTF-activated factors may limit p75 ICD -mediated apoptosis.
Suppression of Rho-A activation
Suppressed activation of Rho-A occurs after RIP of p75 NTR . The release of Rho-GDP from Rho-GDP dissociation inhibitor (Rho-GDI) allows the GDP-bound form to be activated by guanine nucleotide exchange factors (GEF) probably by direct interaction of Rho-GDI with p75 NTR , an event that liberates Rho-GDP for conversion into its active form (Yamashita et al., 2002; Yamashita and Tohyama, 2003) . It is probable that RIP of p75 NTR perturbs the interaction of Rho-GDI with p75 NTR , thereby preventing Rho-A activation through a failure of Rho-GDP/Rho-GDI dissociation. Accordingly, NTF may stimulate RGC axon regeneration after intravitreal sciatic nerve implantation by promoting actin polymerization in RGC growth cones after paralysis
Disinhibition of CNS axon regeneration
Brain ( 2006), 129, 1517-1533 of p75 NTR inhibitory signalling (Amano et al., 2000; Tang, 2003) .
Our results conflict with those of a recent in vitro study that suggests that the induction of RIP of p75 NTR is a prerequisite for inhibitory Rho-A signalling in immature cerebellar granule cells co-cultured with MAG Fc expressing CHO cells (Domeniconi et al., 2005) . In contrast, we show both in vivo and in primary adult retinal cultures that p75 NTR fragmentation disinhibits CNS axon regeneration/neurite outgrowth in the presence of inhibitory CNS myelin. Using the same in vivo adult rat optic nerve injury model used here, Logan et al. (2006) intravitreally implanted engineered fibroblasts expressing single and combined NTF genes and demonstrated that RIP of p75 NTR correlate with suppressed Rho activation and enhanced RGC axon regeneration. Furthermore, in vitro combinations of NTF proteins promote RGC neurite outgrowth in the presence of inhibitory CNS myelin, which also correlates with both RIP of p75 NTR and reduced Rho activation (Logan et al., 2006) . In the current study, we show that Schwann cellderived factors stimulate the secretion and secretion of TACE (known to activate RIP of p75 NTR ), and the exogenous addition of TACE to RGC cultures both stimulates RIP of p75 NTR and reduces Rho activation, enhancing RGC neurite outgrowth in the presence of inhibitory CNS myelin. Blocking EGFR phosphorylation disinhibits axon growth mediated by CNS myelin and CSPG (Koprivica et al., 2005) . In our in vivo and in vitro experiments, EGFR phosphorylation is also blocked after RIP of p75 NTR , disinhibiting RGC axon regeneration/neurite outgrowth in the presence of CNS myelin. In all of the experiments where we have demonstrated that RIP of p75 NTR is associated with NTF-enhanced axon/neurite outgrowth, we have utilized physiological in vivo and in vitro models relevant to the phenomena of adult CNS injury that have a number of key differences to the Domeniconi et al. (2005) in vitro paradigms, including (i) in vivo activation of p75 NTR RIP in NTF-stimulated adult CNS neurons; (ii) induction of adult neurite growth inhibition in cultured primary adult neurons by adding CNS myelin extracts [containing Nogo-A, MAG, OMgp and CSPG (Ahmed et al., 2005b) ] directly to media, rather than by the exclusive in vitro use of MAG Fc expressing CHO cells immature CNS neurons; and (iii) addition of NTF that potentiates RIP of p75 NTR in cultured adult RGC; and (iv) reciprocal co-ordination of p75 NTR and its fragments (p75 ECD and p75 ICD ) (Logan et al., 2006) . NTR Shao et al., 2005) . There is limited fragmentation of TROY at 8 and 20 dpi in both RM and NRM retinae and optic nerves, possibly mediated by shedding mechanisms similar to RIP, with increased levels of the shed fragment in the RM compared with the NRM. However, as knockdown of p75 NTR abolishes Rho-GTP in the presence of significant levels of intact TROY, the myelin-derived factors do not seem to be actively signalling inhibition of RGC axon regeneration though TROY-activated Rho-GTP. Hence the role of TROY in RGC remains an enigma.
Consistent with other reports (reviewed by Hunt et al., 2002 and Sandvig et al., 2004) , we confirm that although levels of NgR rise post-injury levels of full-length NgR are little modulated during RGC axon regeneration after intravitreal sciatic nerve implantation, but NgR ECD is shed after TACE administration, when the shed fragment may act as a dominant-negative signalling antagonist by binding all CNS myelin-derived ligands (Walmsley et al., 2004 (Walmsley et al., , 2005 .
The addition of TACE to NTF-stimulated cultured RGC activates RIP of p75 NTR and NgR ECD shedding, blocks Rho-A activation, reduces EGFR phosphorylation and enhances NTF-stimulated RGC neurite outgrowth in the presence of inhibitory CNS myelin. CNS myelin inhibition is also mediated by NgR-dependent activation of EGFR (Koprivica et al., 2005) . Dysfunction of the NgR/p75 NTR complex after RIP and NgR ECD shedding attenuates EGFR phosphorylation and potentiates disinhibition of RGC axon growth. TACE-initiated RIP of p75 NTR in the absence of NTF does not promote significant neurite outgrowth of RGC cultured with CNS myelin, suggesting that priming neurons to 'growth readiness' together with the removal/neutralization of inhibitory molecules is required to maximize neurite/axon outgrowth, possibly explaining the minimal axon growth seen by others when disinhibition strategies are used without concomitant NTF treatment (Fischer et al., 2004; Steinmetz et al., 2005) . In PN no ONC controls, increased GAP-43 expression correlates with a corresponding increase in TACE production and RIP of p75 NTR . However, other optic nerve lesioned controls without intravitreal PN implantation show no modulation of either p75 NTR or TACE, ruling out the possibility that inflammatory cell-derived factors (Yin et al., 2003) contribute significantly to receptor shedding.
siRNA knockdown of p75 NTR mRNA
Since the processed forms of p75 NTR , including p75 ICD , potentially retain signalling activity in vivo (Kanning et al., 2003) , we investigated whether the complete removal of p75 NTR by siRNA in vitro enhanced CNTF-stimulated neurite outgrowth of RGC grown with CNS myelin. Levels of p75 NTR protein, and downstream Rho-A activation, are completely suppressed by p75 NTR siRNA (sequence 2) in retinal cultures containing CNS myelin ligands. After p75 NTR silencing, the neurite outgrowth seen in response to CNTF in the presence of CNS myelin is significantly enhanced above that seen with CNTF in the absence of myelin. Disinhibited CNTF-stimulated neurite outgrowth rose 2-fold after siRNA treatment, suggesting that the potency of CNTF is normally held in check by other non-myelin-derived inhibitory ligands signalling through the Rho-A pathway, which might include CSPG, ephrins, tenascins and semaphorins (Hunt et al., 2002; Sandvig et al., 2004) . Removal of p75 NTR by siRNA significantly promotes RGC survival in vitro, probably because p75 ICD apoptotic signalling is prevented. In the absence of a functional NgR/p75 NTR complex, p75 ECD no longer acts as a p75 NTR competitive signalling antagonist, although inactivation of EGFR might have been predicted, leading to enhanced disinhibition, since EGFR-mediated inhibition is NgR-dependent (Koprivica et al., 2005) .
In support of our in vitro observations using siRNA, transgenic mice over-expressing NGF grow significant numbers of sympathetic axons within myelinated portions of the maturing and adult brain, and their growth responsiveness to NGF is enhanced if p75 NTR is simultaneously knocked out (Walsh et al., 1999) . This suggests that NTF-stimulated growth of CNS axons into myelin-rich areas is facilitated by the same NTF-induced RIP of p75 NTR observed by us in the present experiments.
Summary
We provide evidence for a novel model of Schwann cell factor-/NTF-stimulated optic nerve regeneration that proposes that RIP of p75 NTR and p75 NTR /TROY/NgR ECD shedding blocks inhibitory signalling through suppressed Rho-A activation and reduced EGFR phosphorylation in RGC, promoting actin polymerization in axonal growth cones and disinhibiting regeneration through the inhibitory environment of the optic nerve. Disinhibition is further potentiated by (i) fragmentation of Nogo-A, (ii) shedding of NgR ECD , which acts as a dominant-negative signalling antagonist by binding all myelin-derived ligands, and (iii) competition between p75 ECD and full-length p75 NTR for NgR binding (Fig. 9) . The resulting dysfunction of the NgR/p75 NTR complex inactivates EGFR, disinhibiting CNS axon growth further, since CNS myelin/CSPG inhibition mediated by EGFR requires upstream NgR activation and Ca 2+ -influx. (1) NTF released from Schwann cells in intravitreal PN grafts stimulate the production of pro-TACE in RGC somata; (2) pro-TACE is anterogradely transported in RGC axons to growth cones in the optic nerve; (3) active TACE (a-secretase) cleaves p75 ECD from P75 NTR leaving p75 CTF in the cytosol; (4) g-secretase cleaves p75 ICD from p75 CTF ; and (5) cytosolic p75 ICD somehow blocks activation of Rho-GDP. Disinhibition is potentiated by (6) shedding of the NgR ECD that acts as a soluble dominant-negative inhibitory signalling antagonist binding all myelin-derived ligands; (7) competition for NgR binding between shed soluble p75 ECD and full-length 75 NTR ; and (8) blocking of inhibitory signalling by multiple soluble Nogo-A fragments, probably produced by MMP secreted from RGC axon growth cones/optic nerve glia. A role for TROY in disinhibition is yet to be determined. In our RM, disinhibition is potentiated by suppressed phosphorylation of EGFR secondary to NgR/p75 NTR inactivation and reduced Ca 2+ influx.
